Vanguard Group Inc. Sells 145,481 Shares of LHC Group, Inc. (LHCG)
Vanguard Group Inc. reduced its position in LHC Group, Inc. (NASDAQ:LHCG) by 4.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,916,228 shares of the health services provider’s stock after selling 145,481 shares during the period. Vanguard Group Inc. owned about 9.30% of LHC Group worth $300,343,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in LHCG. Janus Henderson Group PLC purchased a new stake in LHC Group in the 2nd quarter worth approximately $369,000. Legal & General Group Plc grew its stake in LHC Group by 85.4% in the 2nd quarter. Legal & General Group Plc now owns 63,040 shares of the health services provider’s stock worth $5,397,000 after acquiring an additional 29,042 shares during the period. PNC Financial Services Group Inc. grew its stake in LHC Group by 750.3% in the 2nd quarter. PNC Financial Services Group Inc. now owns 12,397 shares of the health services provider’s stock worth $1,060,000 after acquiring an additional 10,939 shares during the period. FMR LLC grew its stake in LHC Group by 297.8% in the 2nd quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock worth $98,548,000 after acquiring an additional 861,952 shares during the period. Finally, Glen Harbor Capital Management LLC grew its stake in LHC Group by 29.2% in the 2nd quarter. Glen Harbor Capital Management LLC now owns 3,910 shares of the health services provider’s stock worth $335,000 after acquiring an additional 884 shares during the period. 87.79% of the stock is owned by hedge funds and other institutional investors.
Shares of LHCG opened at $97.61 on Monday. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of 40.33, a P/E/G ratio of 1.36 and a beta of 0.88. LHC Group, Inc. has a fifty-two week low of $58.65 and a fifty-two week high of $107.51. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.17.
Several research firms have commented on LHCG. Bank of America set a $119.00 target price on shares of LHC Group and gave the stock a “buy” rating in a research note on Tuesday, September 18th. William Blair reaffirmed a “buy” rating on shares of LHC Group in a research note on Thursday, November 1st. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $105.00 target price for the company in a research note on Wednesday, January 2nd. Barclays began coverage on shares of LHC Group in a research note on Friday, December 14th. They issued an “equal weight” rating and a $105.00 target price for the company. Finally, Craig Hallum cut shares of LHC Group from a “buy” rating to a “hold” rating and lowered their target price for the stock from $99.00 to $92.00 in a research note on Friday, October 26th. Four analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $105.77.
In other LHC Group news, CEO Keith G. Myers sold 6,790 shares of LHC Group stock in a transaction on Monday, January 7th. The shares were sold at an average price of $95.01, for a total value of $645,117.90. Following the transaction, the chief executive officer now owns 155,475 shares in the company, valued at approximately $14,771,679.75. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $95.10, for a total transaction of $7,132,500.00. Following the completion of the transaction, the chief executive officer now owns 200,765 shares in the company, valued at approximately $19,092,751.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 241,821 shares of company stock worth $23,703,540. 6.80% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/vanguard-group-inc-sells-145481-shares-of-lhc-group-inc-lhcg/2744898.html.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Featured Story: Understanding Analyst Ratings
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.